Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11C-PIB PET/CT in Parkinson's Disease and Parkinsonian Dementia
NCT03555292Phase 2Unknown
- Sponsor
- Oriental Neurosurgery Evidence-Based-Study Team
- Start
- Jul 2017
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 2, open-label trial (5 arms), sponsored by Oriental Neurosurgery Evidence-Based-Study Team. Primary endpoint: Amyloid burden range in all subjects at 1 week. Status: unknown.
Beyond the preview
Go deeper on NCT03555292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03555292.